您的位置: 首页 > 农业专利 > 详情页

Mediated by Dendritic Cell Immunoreceptors (DCIR) Cross-Priming of Human CD8 + T Cells
专利权人:
Бейлор Рисёч Инститьют (US)
发明人:
БАНШЕРО Жак Ф. (US),КЛЕЧЕВСКИ Эйнав (IL),ЗУРАВСКИ Герард (US),ЗУРАВСКИ Сандра (US)
申请号:
RU2012152828/10
公开号:
RU2012152828A
申请日:
2011.05.04
申请国别(地区):
RU
年份:
2014
代理人:
摘要:
1. An immunostimulatory composition for generating an immune response, for prophylaxis, therapy, or any combination thereof in a human or animal object, comprising: one or more dendritic cell (DC) specific antibodies or fragments thereof, loaded or chemically linked to one or several antigenic peptides, where antigenic peptides are typical representatives of one or more epitopes of one or more antigens involved in or involved in a disease or condition against which an immune response, prophylaxis, therapy, or any combination thereof; at least one toll-like receptor (TLR) agonist selected from the group consisting of TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR7 and TLR8 agonists, and pharmaceutically acceptable a carrier, where each of the conjugate and agonist is contained in such a quantity that, in combination with the other one, it is effective for eliciting an immune response, for prevention, for therapy or any combination thereof in a human object or animal object in need of immunostimulation. 2 . The composition of claim 1, wherein the composition includes one or more optional agents selected from the group consisting of an anti-CD40 agonist antibody, a CD40 agonistic antibody fragment, a CD40 ligand polypeptide (CD40L), a CD40L polypeptide fragment, an anti-4-1BB antibody, an antibody fragment 4-1BB, ligand 4-1BB polypeptide, fragment of 4-1BB ligand polypeptide, IFN-γ, TNF-α, type 1 cytokines, type 2 cytokines, or combinations and modifications thereof. 3. The composition of claim 1, wherein the DC-specific antibody or fragment is selected from an antibody that specifically binds to a dendritic cell immunoreceptor (DCIR)1. Иммуностимулирующая композиция для формирования иммунного ответа, для профилактики, терапии или их любой комбинации у объекта-человека или объекта-животного, включающая:одно или несколько специфических к дендритной клетке (DC) антител или их фрагментов, нагруженных или химически связанных с одним или несколькими антигенными пептидами, где анти
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充